Early trial halted for advanced breast cancer treatment
Disease control
Terminated
This early-stage study aimed to find a safe dose for combining two drugs (infigratinib and tamoxifen) to treat advanced breast cancer with specific genetic changes. It enrolled only 4 participants before being terminated. The main goal was to identify side effects and determine i…
Phase: PHASE1 • Sponsor: Jennifer Lee Caswell-Jin • Aim: Disease control
Last updated Feb 17, 2026 14:40 UTC